The APAC Precision Oncology Conference 2025, themed Artificial Intelligence (AI) & Multi-omics in Cancer Management, co ...
This article introduces the field of bioinformatics and its importance as a cornerstone of biological research, as well as ...
Innovative studies in diagnostic applications of artificial intelligence will be presented at the Association for Molecular Pathology (AMP) 2025 Annual Meeting & Expo, taking place Nov. 11–15 in ...
At ASHG, Illumina launches 5-base and shows exciting results from constellation, a breakthrough technology offering ...
Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...
Artificial intelligence can be a helpful agriculture tool, but it's not a good idea to be solely dependent on it.
Will partner USA’s 10X Health and UK’s REVIV Global to deliver hyper-personalised solutions using genetic insights, blood ...
The global AI chip market has grown to $166.9 billion in 2025, and is predicted to reach $311.58 billion by 2029, ...
One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, ...
As India’s healthcare sector is widening with the rise of patients, the need for effective and quick diagnostics is also ...
MARTi enables real-time nanopore metagenomics, helping researchers detect and respond to microbial threats across diverse environments.
Emirates News Agency on MSN
M42, 10X Health, REVIV Global partner to launch '10XREVIV' for precision health
M42, a global health leader powered by technology, AI and genomics, has announced a strategic partnership with 10X Health (USA) and REVIV Global (UK) to launch 10XREVIV, a pioneering venture set to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results